Fenwick represented Lotus Health AI, an AI-powered primary care platform delivering free, doctor-reviewed personalized health solutions, in its $35 million Series A financing. The round was co-led by CRV and Kleiner Perkins.
Lotus Health AI will use the funds to scale its infrastructure to serve millions, strengthen its world-class clinical team, and sustain free care as the company grows. More information can be obtained from the company announcement.
The Fenwick transaction team was led by corporate partner Jordan Roberts and included associate Stephanie Hong.